Picture of Francis Dehle

Francis Dehle PhD

Director, Market Access - BBioMedSc, PhD Pharmacology

Intro

Francis has over 10 years of experience at HTANALYSTS and industry managing PBAC and MSAC reimbursement submissions.

Biography

Dr Francis Dehle joined HTANALYSTS in July 2011 and is now an Associate Director. While with HTANALYSTS, Francis has contributed to reimbursement submissions to PBAC and MSAC, observational study design reporting, global health economic model adaptations, feasibility briefs and preparation of manuscripts. Between 2015 and 2018, Francis worked for Boehringer Ingelheim where he managed and contributed to submissions to the PBAC in the areas of diabetes and respiratory diseases. Francis re-joined HTANALYSTS in October 2018. During his career, Francis has conducted numerous systematic reviews including of RCTs, observational studies, and economic literature in the therapeutic areas of Alzheimer’s disease, asthma, COPD, diabetes, osteoporosis, oncology and osteoarthritis.

Prior to joining HTANALYSTS, Francis worked as a post-doctoral researcher at the Department of Thoracic Medicine, Royal Adelaide Hospital and the School of Chemistry & Physics, The University of Adelaide. Francis completed a PhD in Pharmacology at The University of Adelaide and has published a number of articles on macrophage function in COPD and lung cancer, and the protein dynamics of amyloid formation in peer-reviewed journals.

Menu